论文部分内容阅读
1977年4月前,高密度脂蛋白-胆固醇(HDL-Chol)测定只用于临床研究。自作者那时介绍此测定后三年以来,其化验检样从零增到每周10,000份。作者预言,此量将在一年内翻一翻。血清HDL-Chol值是冠心病(CHD)危险性的予示指标:CDL-Chol检查始用于预防医学,以预示机体发生CHD危险的可能性,识别这些易患人群的重要性在于从饮食、药物控制及体育锻炼着手,来预防和延迟CHD的发生。现确认血清HDL-Chol值是预示CHD危险性最好的脂质指标,它似比总胆固醇(T-Chol)敏感。Framinghan等的几组大系列流行病学研究表明,CHD的危险性单与
By April 1977, the HDL-Chol assay was only used for clinical studies. Since then, three years after the author introduced the assay, his laboratory samples increased from zero to 10,000 per week. The authors predict that this amount will double in a year. Serum HDL-Chol is a predictor of CHD risk: The CDL-Chol test was used prophylactically to predict the risk of developing CHD in the body. The importance of identifying these predisposed groups is that diet, Drug control and physical activity to prevent and delay the occurrence of CHD. Serum HDL-Chol values are now confirmed to be the best indicator of CHD risk lipid targets, it seems more than the total cholesterol (T-Chol) sensitive. Several large series of epidemiological studies by Framinghan et al. Show that the risk of CHD alone and